Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine

European Neuropsychopharmacology

Volumn 18, Issue 7, 2008, Pages 498-507

  Marek, Gerard J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antidepressant drugs; Excitatory postsynaptic currents; Interneurons; Piriform cortex; Prefrontal cortex; Pyramidal cells

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; IMIPRAMINE; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOWN REGULATION; DRUG RECEPTOR BINDING; ELECTRIC SHOCK; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; INTERMETHOD COMPARISON; MALE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; UPREGULATION;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EXCITATORY AMINO ACID AGONISTS; IMIPRAMINE; MALE; MEMBRANE POTENTIALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN;

EID: 44249125254     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.01.003     Document Type: Article

References (94)

1. Aghajanian G.K., and Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36 (1997) 589-599
2. 1a receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40 (1991) 399-412
3. 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc. Natl. Acad. Sci. U. S.A. 104 (2007) 9870-9875
4. Biegon A., and Israeli M. Quantitative autoradiographic analysis of the effects of electroconvulsive shock on serotonin-2 receptors in male and female rats. J. Neurochem. 48 (1987) 1386-1391
5. Blackshear M.A., and Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J. Pharmacol. Exp. Ther. 221 (1982) 303-308
6. Blendy J.A., Grimm L.A., Perry D.C., West-Johnsrud L., and Kellar K.J. Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain. J. Neurosci. 10 (1990) 2580-2588
7. 1a-adrenoceptor binding sites in rat cerebral cortex. J. Neurochem. 57 (1991) 1548-1555
8. Blendy J.A., Stockmeier C.A., and Kellar K.J. Electroconvulsive shock and reserpine increase a1-adrenoceptor binding sites but not norepinephrine-stimulated phosphoinositide hydrolysis in rat brain. Eur. J. Pharmacol. 156 (1988) 267-270
9. Bobula B., Tokarski K., and Hess G. Repeated administration of antidepressants decreases field potentials in rat frontal cortex. Neuroscience 120 (2003) 765-769
10. 2 receptors induced in rat frontal cortex by repeated imipramine and citalopram. Naunyn Schmiedebergs Arch. Pharmacol. 367 (2003) 444-450
11. Bortolozzi A., Diaz-Mataix L., Scorza M.C., Celada P., and Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 95 (2005) 1597-1607
12. 2A receptor expression. NeuroReport 6 (1995) 901-904
13. Burnet P.W.J., Michelson D., Smith M.A., Gold P.W., and Sternberg E.M. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638 (1994) 311-324
14. Burnett P.W.J., Sharp T., LeCorre S.M., and Harrison P.J. Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock. Neurosci. Lett. 277 (1999) 79-82
15. Butler M.O., Morinobu S., and Duman R.S. Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex. J. Neurochem. 61 (1993) 1270-1276
16. Calabrese J.R., Keck P.E.J., McFadden W., Minkwitz M., Ketter T.A., Weisler R.H., Cutler A.J., McCoy R., Wilson E., Mullen J., and Group T.B.S. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 146 (2005) 149-155
17. 2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29 (2004) 1637-1647
18. Chaput Y., de Montigny C., and Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 333 (1986) 342-348
19. 2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology 38 (1999) 533-541
20. Conn P.J., and Sanders-Bush E. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J. Neurosci. 6 (1986) 3669-3675
21. Dall'Olio R., Gaggi R., Bonfante V., and Gandolfi O. The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function. Behav. Pharmacol. 10 (1999) 63-71
22. De Montigny C., and Aghajanian G.K. Tricyclic antidepressants: long-term treatment increases responsivity for rat forebrain neurons to serotonin. Science 202 (1978) 1303-1306
23. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., and Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry 47 (1990) 411-418
24. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., and Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol. Psychiatry (1999) 212-220
25. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
26. Eison A.S., Eison M.S., Yocca F.D., and Gianutsos G. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation. Life Sci. 44 (1989) 1419-1427
27. Eison A.S., Freeman R.P., Guss V.B., Mullins U.L., and Wright R.N. Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat. J. Pharmacol. Exp. Ther. 273 (1995) 304-308
28. Gewirtz J.C., and Marek G.J. Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 23 (2000) 569-576
29. Godfrey P.P., McClue S.J., Young M.M., and Heal D.J. 5-hydroxytryptamine-stimulated inositol phospholipid hydrolysis in the mouse cortex has pharmacological characteristics compatible with mediation via 5-HT2 receptors but this response does not reflect altered 5-HT2 function after 5,7-dihydroxytryptamine lesioning or repeated antidepressant treatments. J. Neurochem. 50 (1988) 730-738
30. 2 receptor-mediated head-twitch behavior following antidepressant treatment to mice. Br. J. Pharmacol. 83 (1984) 235-242
31. 2 receptors in the medial prefrontal cortex: behavioral studies. Soc. Neurosci. Abstr. 18 (1992) 1380
32. Gray J.A., Sheffler D.J., Bhatnagar A., Woods J.A., Hufeisen S.J., Benovic J.L., and Roth B.L. Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine2A receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Mol. Pharmacol. 60 (2001) 1020-1030
33. 2A receptors in heterologous expression systems. J. Neurochem. 63 (1994) 1255-1260
34. 1A receptors. J. Neurosci. 18 (1998) 10150-10156
35. 2-adrenoceptors. Neuropharmacolgy 21 (1982) 507-510
36. Handley S.L., and Singh L. Neurotransmitters and shaking behaviour - more than a 'gut-bath' for the brain. Trends in Pharmacol. Sci. (1986) 324-328
37. 1-adrenoceptors in the frontal cortex of the rat. Neuropharmacolgy 31 (1992) 955-960
38. Kellar K.J., and Bergstrom D.A. Electroconvulsive shock: effects on biochemical correlates of neurotransmitter receptors in rat brain. Neuropharmacolgy 22 (1983) 401-406
39. Kellar K.J., Cascio C.S., Butler J.A., and Kurtzke R.N. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur. J. Pharmacol. 69 (1981) 515-518
40. Kendall D.A., and Nahorski S.R. 5-hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J. Pharmacol. Exp. Ther. 233 (1985) 473-479
41. 2A receptor in ACTH-treated rats. Pharmacol. Biochem. Behav. 72 (2002) 397-402
42. 2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39 (2000) 471-481
43. Lambe E.K., and Aghajanian G.K. The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J. Neurosci. 21 (2001) 9955-9963
44. Laruelle M., Abi-Dargham A., Casanova M.F., Toti R., Weinberger D.R., and Kleinman J.E. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. Arch. Gen. Psychiatry 50 (1993) 810-818
45. Lebrecht U., and Nowak J.Z. Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain-II behavioural studies. Neuropharmacology 19 (1980) 1055-1061
46. Little J.T., Ketter T.A., Mathe A.A., Frye M.A., Luckenbaugh D., and Post R.M. Venlafaxine, but not bupropion, decreases cerebrospinal fluid 5-hydoxyindoleacetic acid in unipolar depression. Biol. Psychiatry 45 (1999) 285-289
47. Maj J., Bijak M., Dziedzicka-Wasylewska M., Rogoz R., Rogoz Z., Skuza G., and Tokarski T. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology 127 (1996) 73-82
48. 2A receptor interactions. Eur. J. Pharmacol. 474 (2003) 77-83
49. 1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur. J. Pharmacol. 367 (1999) 197-206
50. 2A receptor antagonist. Eur. J. Pharmacol. 259 (1994) 137-141
51. Marek G.J., Wright R.A., Schoepp D.D., Monn J.A., and Aghajanian G.K. Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex. J. Pharmacol. Exp. Ther. 292 (2000) 76-87
52. 2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28 (2003) 402-412
53. 2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 30 (2005) 2205-2215
54. Marek G.J., Wright R.A., Gewirtz J.C., and Schoepp D.D. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105 (2001) 379-392
55. McMahon F.J., Buervenich S., Charney D.S., Lipsky R., Rush A.J., Wilson A.F., Sorant A.J.M., Papanicolaou G.J., Laje G., Fava M., Trivedi M.H., Wisniewski S.R., and Manji H. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Amer. J. Human Genet. 78 (2006) 804-814
56. 1A-adrenoceptors mediate inositol phosphate generation. Naunyn-Schmiedebergs Arch. Pharmacol. 341 (1990) 385-387
57. 2 receptor-mediated head shakes but not brain c-fos induction. Neuropharmacology 35 (1996) 303-313
58. Murphy G.M.J., Kremer C., Rodriques H.E., and Schatzberg A.F. Pharmacogenetics of antidepressant medication intolerance. Am. J. Psychiatry 160 (2003) 1830-1835
59. Newman M.E., Mishkin I., and Lerer B. Effects of single and repeated electroconvulsive shock administration on inositol phosphate accumulation in rat brain slices. J. Neurochem. 49 (1987) 19-23
60. 2A receptor on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111 (2002) 163-176
61. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., Roberts R.C., Conley R.R., and Tamminga C.A. Higher expression of 5-HT2A receptors in the postmortem brains of teenage suicide victims. Am. J. Psychiatry 159 (2002) 419-429
62. 1-adrenoceptors and phosphoinositide signalling system in rat brain. Eur. J. Pharmacol. 226 (1992) 303-310
63. Pehek E.A., McFarlane H.G., Maguschak K., Price B., and Pluto C.P. M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res. 888 (2001) 51-59
64. Pehek E.A., Nocjar C., Roth B.L., Byrd T.A., and Mabrouk O.S. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31 (2006) 265-277
65. Peroutka S.J., and Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210 (1980) 88-90
66. Pilc A., Chalecka-Franaszek E., Nalepa I., Vetulani J., and Enna S.J. The influence of electroshock on adrenoceptor function in rat brain cerebral cortex: selectivity for the a-adrenoceptor site. Eur. J. Pharmacol. 156 (1988) 143-147
67. Read H.L., Beck S.G., and Dun N.J. Serotonergic suppression of interhemispheric cortical synaptic potentials. Brain Res. 643 (1994) 17-28
68. Riblet L.A., and Taylor D.P. Pharmacology and neurochemistry of trazodone. J. Clin. Psychopharmacol. 1 (1981) 17S-22S
69. Richelson E. Pharmacology of antidepressants. Mayo Clin. Proc. 76 (2001) 511-527
70. Roth B.L., and Xia Z. Molecular and cellular mechanisms for the polarized sorting of serotonin receptors: relevance for genesis and treatment of psychosis. Crit. Rev. Neurobiol. 16 (2004) 229-236
71. Rueter L.A., De Montigny C., and Blier P. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems. J. Pharmacol. Exp. Ther. 285 (1998) 404-412
72. Sanders-Bush E., Breeding M., Knoth K., and Tsutsumi M. Sertraline-induced desensitization of the serotonin 5-HT-2 receptor transmembrane signalling system. Psychopharmacology 99 (1989) 64-69
73. Schreiber R., Brocco M., Audinot V., Gobert A., Veiga S., and Millan M.J. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine(5-HT)2A receptors: Modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J. Pharmacol. Exp. Ther. 273 (1995) 101-112
74. 2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci. 20 (2000) 8846-8852
75. 2 receptors in interneurons. Synapse 9 (1991) 208-218
76. 2-activated interneuron. Brain Res. 506 (1990) 62-69
77. q protein. Neuropharmacology 51 (2006) 524-535
78. Stanley M., and Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1 8318 (1983) 214-216
79. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., and Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16 (1997) 162-173
80. Stockmeier C.A., and Kellar K.J. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci. 38 (1986) 117-127
81. Subhash M.N., and Jagadeesh S. Imipramine-induced changes in 5-HT2 receptor sites and inositoltrisphosphate levels in rat brain. Neurochem. Res. 22 (1997) 1095-1099
82. Tanaka E., and North R.A. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J. Neurophysiol. 69 (1993) 1749-1757
83. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dube S., Tollefson G.D., and Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatr. 60 (2003) 1079-1088
84. Umbricht D., Vollenweider F.X., Schmid L., Grubel C., Skrabo A., Huber T., and Koller R. Implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28 (2003) 170-181
85. Underwood M.D., Mann J.J., and Arango V. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcoholism: Clin. Exp. Res. 28 (2004) 57S-69S (May Suppl)
86. Vetulani J., Lebrecht U., and Pilc A. Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. Eur. J. Pharmacol. 76 (1981) 81-85
87. 2C receptor agonists. Pharmacol. Biochem. Behav. 69 (2001) 643-652
88. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F.I., Babler A., Vogel H., and Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 9 (1998) 3897-3902
89. 2A receptor signalling modulates anxiety-like behaviors in mice. Science 313 (2006) 536-540
90. Willins D.L., Deutch A.Y., and Roth B.L. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27 (1997) 79-82
91. Winstanley C.A., Chudasama Y., Dalley J.W., Theobald D.E.H., Glennon J.C., and Robbins T.W. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology 167 (2003) 304-314
92. Winstanley C.A., Theobald D.E.H., Dalley J.W., Glennon J.C., and Robbins T.W. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176 (2004) 376-385
93. Yatham L.N., Liddle P.F., Dennie J., Shiah I.S., Adam M.J., Lane C.J., Lam R.W., and Ruth T.J. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch. Gen. Psychiatry 56 (1999) 705-711
94. Zhang C., and Marek G.J. AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated prefrontal cortical excitatory synaptic currents and DOI-induced head shakes. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32 (2008) 62-71